PO.TB09.01 · 肿瘤生物学

时空性癌细胞轨迹构成胶质母细胞瘤异质性的基础

A spatiotemporal cancer cell trajectory underlies glioblastoma heterogeneity

海报缩略图:时空性癌细胞轨迹构成胶质母细胞瘤异质性的基础
编号 7509 展板 11 时间 4/22 09:00–12:00 区域 Section 31 主讲 Omer Bayraktar
分会场 Tumor Heterogeneity
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Grant De Jong1, Fani Memi1, Tannia Gracia1, Olga Lazareva2, Richard Mair3, Sam Behjati1, Oliver Stegle2, Omer Bayraktar1

1Wellcome Sanger Institute, Cambridge, United Kingdom,2German Cancer Resarch Centre, Heidelberg, Germany,3Cancer Research UK Cambridge Institute, Cambrige, United Kingdom

摘要 Abstract

中文摘要
在胶质母细胞瘤(一种无法治愈的脑肿瘤)中,癌细胞表现出高度异质性和可塑性的状态。然而,这些恶性状态如何产生,以及它们是否在肿瘤间遵循明确的细胞轨迹,尚未得到充分理解。在此,我们构建了一个人类胶质母细胞瘤的深度单细胞和空间多组学图谱,将12个肿瘤跨多个区域的转录组、表观基因组和基因组分析配对。我们发现胶质母细胞瘤的异质性由癌细胞从发育样状态向由胶质损伤反应和缺氧所定义的状态的空间模式化转变所驱动。这一细胞轨迹将肿瘤区域化为不同的组织生态位,并以分子上保守的方式在肿瘤间以及遗传上不同的肿瘤亚克隆间表现出来。此外,通过一种新的深度学习框架将癌细胞状态与克隆在原位联合定位,我们表明肿瘤亚克隆在胶质母细胞瘤组织生态位中精细地空间交织。最后,我们表明这一癌细胞轨迹与髓系异质性密切关联,并在区域化的髓系信号环境中展开。我们的发现定义了胶质母细胞瘤中一条定型化的癌细胞轨迹,并将胶质母细胞瘤的肿瘤异质性统一到一个可处理的细胞和组织框架中。
查看英文原文 English abstract
Cancer cells display highly heterogeneous and plastic states in glioblastoma, an incurable brain tumour. However, how these malignant states arise and whether they follow defined cellular trajectories across tumours is poorly understood. Here, we generated a deep single cell and spatial multi-omic atlas of human glioblastoma that pairs transcriptomic, epigenomic and genomic profiling of 12 tumours across multiple regions. We identify that glioblastoma heterogeneity is driven by spatially-patterned transitions of cancer cells from developmental-like states towards those defined by a glial injury response and hypoxia. This cellular trajectory regionalises tumours into distinct tissue niches and manifests in a molecularly conserved manner across tumours as well as genetically distinct tumour subclones. Moreover, using a new deep learning framework to map cancer cell states jointly with clones in situ, we show that tumour subclones are finely spatially intermixed through glioblastoma tissue niches. Finally, we show that this cancer cell trajectory is intimately linked to myeloid heterogeneity and unfolds across regionalised myeloid signalling environments. Our findings define a stereotyped trajectory of cancer cells in glioblastoma and unify glioblastoma tumour heterogeneity into a tractable cellular and tissue framework.
利益披露 Disclosure
G. De Jong, None.. F. Memi, None.. T. Gracia, None.. O. Lazareva, None.. R. Mair, None.. S. Behjati, None.. O. Stegle, None.. O. Bayraktar, None.

← 返回 AACR 2026 检索